MDLA.JK PT Medela Potentia Tbk

Healthcare Medical Distribution Jakarta Exchange
190.00 IDR
Close of Oct 29, 2026
176.00 274.14
Market cap
IDR 2.65T
P/E
6.5x
P/B
0.87x
ROE
14.4%
Dividend yield
5.19%
Fundamental score
2.9/5

Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.

Is MDLA.JK undervalued?

Graham number
Price190.00
Graham value380.08
Discount50.0%

MDLA.JK trades 50.0% below its Graham number.

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

PT Medela Potentia Tbk fundamental analysis

14 of 22 checks passed

ROE 1/2

Moderate return on equity (14.4%), between 10% and 20%.

ROA 1/1

Return on assets (6.7%) is above the industry median (1.9%).

Profit Consistency 2/2

Profitable for 5 consecutive years.

Earnings Growth 5Y 0/1

Earnings per share history is shorter than 5 years.

Earnings Acceleration 0/1

Not enough positive earnings history to compare last year's growth with the 5-year average.

Earnings Growth vs Industry 0/1

Last year's EPS growth (-19.8%) is below the industry median (2.3%).

Revenue Growth 1/2

Revenue grew 8.4% a year over the past 3 years.

Short-term Liquidity 1/1

Current assets cover short-term liabilities.

Long-term Liabilities 1/1

Current assets cover long-term liabilities.

Debt to Equity 2/2

Low debt to equity (2.3%), 40% or less.

Debt Trend 0/1

Debt to equity history is shorter than 5 years.

Debt Coverage 0/1

Operating cash flow does not cover 20% of total debt.

Interest Coverage 1/1

EBIT is 74.6x against interest expense, well covered.

PE vs Market 1/1

PE (6.5x) is below the market median (12.0x).

PE vs Industry 1/1

PE (6.5x) is below the industry median (12.0x).

PBV 1/1

Price to book (0.9x) is below the industry median (1.2x).

Graham Number 1/1

The price is below the Graham number (PE x PB = 5.7, limit 22.5).

PEG 0/1

PEG needs positive PE and positive 5-year earnings growth.

Dividend Yield 1/2

Dividend yield (5.1%) is above the bottom 25% of dividend payers in the market.

Dividend Stability 0/2

Dividends were not paid steadily for the past 5 years.

Dividend Growth 0/1

Dividends paid did not grow over the past 5 years.

Payout Ratio 1/1

Payout ratio is 35.0%, covered by earnings.

Each check is worth 1 or 2 points by how much it says about the quality of the company. The score is the share of points earned, out of 5. Ask AI to explain this score

PT Medela Potentia Tbk stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About PT Medela Potentia Tbk

PT Medela Potentia Tbk distributes and markets pharmaceutical and healthcare products, and medical devices in Indonesia and Cambodia. It also manufactures medical devices, including consumables and medical equipment for hospitals and laboratories. The company also processes medical device products; and digital platform and web portal activities for human use, as well as pharmaceutical products. In addition, the company develops GoApotik, a B2B2C platform for expanding its pr…

Full company profile